Richard Douglas
Net worth: 1 M $ as of 31/05/2026
Net worth: 1 M $ as of 31/05/2026
Dr. Richard H.
Douglas is an Independent Chairman at MaxCyte, Inc., a Chairman at Aldeyra Therapeutics, Inc. and an Independent Director at Novavax, Inc. He is on the Board of Directors at Novavax, Inc., Valneva Usa, Inc. (United States), Helio Vision, Inc. and Labyrinth Choir, Inc. Dr. Douglas was previously employed as a Senior Vice President-Corporate Development by Genzyme Corp.
and a Director-New Product Development by Integrated Genetics, Inc. He received his undergraduate degree from the University of Michigan and a doctorate degree from the University of California, Berkeley.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVAVAX, INC. 0.04% | 23/04/2026 | 73,220 ( 0.04% ) | 803 223 $ | 31/05/2026 |
| 13/04/2026 | 195,000 ( 0.32% ) | 341 250 $ | 31/05/2026 | |
MAXCYTE, INC. 0.22% | 21/04/2026 | 230,577 ( 0.22% ) | 278 998 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| IOMAI CORPORATION | Director/Board Member | 01/01/2002 |
| NOVAVAX, INC. | Director/Board Member | 06/08/2010 |
| ALDEYRA THERAPEUTICS, INC. | Chairman | - |
| MAXCYTE, INC. | Chairman | 03/11/2021 |
Labyrinth Choir, Inc.
Labyrinth Choir, Inc. Media ConglomeratesConsumer Services Labyrinth Choir is a choral organization based in Southborough, MA. Labyrinth Choir, Inc. consists of a professional choral conductor, twenty professional singers, and a professional accompanist. The company present theme-based concerts opens to the public and support professional musicians by compensating them for rehearsals and concerts. The company's repertoire includes a wide range of musical styles and languages. Labyrinth Choir's mission is to encourage audience participation and collaboration with artists and other ensembles. The company also aims to provide opportunities for young singers and conductors through workshops and performances with music students from local schools. | Director/Board Member | - |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Develop a therapy for fibro proliferative disorders that lead to abnormal scarring and blindness after retina surgery | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/01/2011 |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Corporate Officer/Principal | 01/01/1989 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Novavax, Inc.
Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Develop a therapy for fibro proliferative disorders that lead to abnormal scarring and blindness after retina surgery | Health Technology |
Labyrinth Choir, Inc.
Labyrinth Choir, Inc. Media ConglomeratesConsumer Services Labyrinth Choir is a choral organization based in Southborough, MA. Labyrinth Choir, Inc. consists of a professional choral conductor, twenty professional singers, and a professional accompanist. The company present theme-based concerts opens to the public and support professional musicians by compensating them for rehearsals and concerts. The company's repertoire includes a wide range of musical styles and languages. Labyrinth Choir's mission is to encourage audience participation and collaboration with artists and other ensembles. The company also aims to provide opportunities for young singers and conductors through workshops and performances with music students from local schools. | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions